Antibacterial activity of 1,8-cineole and α-terpineol bioactive from cardamom against multi-drug-resistant Escherichia coli isolated from urinary tract infections-an in vitro study
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20242415Keywords:
1,8-cineole, α-terpineol, Escherichia coli, MDR, UTIsAbstract
Background: Urinary tract infections (UTIs) are some of the most commonly encountered infections in clinical practice that affects 150 million people each year worldwide. The emergence of resistance, adverse effects of antimicrobial agents, and other related issues have prompted the establishment of a research framework to explore alternative methods for managing UTIs. Cardamom exhibits unique botanical characteristics and biochemical compositions, contributing to their diverse culinary and medicinal applications. Techniques like gas chromatography-mass spectrometry analysis have identified 1,8-cineole and a-terpineol as main bioactive components in both black and green cardamom. Present study addresses urgent, unmet analytical and clinical care needs by exploring adoption of alternative therapies, specifically nutraceuticals viz, 1, 8-cineole and α-terpineol, major bioactive from cardamon for controlling and treating UTIs.
Methods: Different concentrations of 1,8-cineole, α-terpineol and 1,8-cineole/α-terpineol (1:1) were used to determine the minimum inhibitory concentration (MIC) and minimum bactericidal concentration (MBC) against multi-drug resistant (MDR) E. coli isolated from UTIs.
Results: The mean MIC and MBC of 1,8-cineole, α-terpineol and 1,8-cineole/α-terpineol (1:1) for MDR E. coli strains were 7.73 µg/ml, 0.32 µg/ml and 0.32 µg/ml respectively. For non MDR E. coli strains the mean MIC and MBC of the 1, 8-cineole, α-terpineol and 1,8-cineole/α-terpineol (1:1) were 2.14 µg/ml, 0.2 µg/ml and the 0.2 µg/ml respectively.
Conclusions: 1,8-cineole and α-terpineol exhibited good antimicrobial activity against urinary E. coli isolates tested, including MDR strains.
References
Al Lawati H, Blair BM, Larnard J. Urinary Tract Infections: Core Curriculum 2024. Am J Kidney Dis. 2024;83(1):90-100.
Kader AA, Kumar AK. Prevalence of extended spectrum beta-lactamase among multidrug resistant gram-negative isolates from a general hospital in Saudi Arabia. Saudi Med. J. 2004;25:570-74.
Sarojamma V, Ramakrishna V. Prevalence of ESBL-producing Klebsiella pneumoniae isolates in tertiary care hospital. Int. Sch. Res. Not. 2011;2011:318348.
Chiang CY, Uzoma I, Moore RT, Gilbert M, Duplantier AJ, Panchal RG. Mitigating the impact of antibacterial drug resistance through host-directed therapies: Current progress, outlook, and challenges. MBio. 2018;9:e01932-17.
Saipriya JB, Shubha DS, Sudhindra KS, Sumantha A, Madhuri KR. Clinical importance of emerging ESKAPE pathogens and antimicrobial susceptibility profile from a tertiary care centre. Int J Curr Microbiol Appl Sci. 2018;7:2881-91.
Gharavi MJ, Zarei J, Roshani-Asl P, Yazdanyar Z, Sharif M, Rashidi N. Comprehensive study of antimicrobial susceptibility pattern and extended spectrum beta-lactamase (ESBL) prevalence in bacteria isolated from urine samples. Sci Rep. 2021;11:1-11.
Fazly Bazzaz BS, Darvishi Fork S, Ahmadi Rl. Deep insights into urinary tract infections and effective natural remedies. Afr J Urol. 2021;27:6.
Abdullah, Ahmad N, Tian W, Zengliu S, Zou Y, Farooq S, et al. Recent advances in the extraction, chemical composition, therapeutic potential, and delivery of cardamom phytochemicals. Front Nutr. 2022;9:1024820.
Singhal P, Gautam GK, Ravi K, Gaurav K. A Review on Amomum subulatum and Elettaria Cardamomum with their Pharmacological Activity. Recent Trends Pharmaceut Sci Res. 2022;4(1):1-6
Prabhu P, Edayadulla N, and Anand S. “In Vitro Antibacterial Activity and Gas Chromatography-Mass Spectrometry Analysis of Ethanolic Extract Of Leaves Of Elettaria Cardamomum L. Maton”. Asian J Pharmaceut Clin Res. 2019;12(1):73-5.
Masyita A, Mustika Sari R, Dwi Astuti A, Yasir B, Rahma Rumata N, Emran TB, et al. Terpenes and terpenoids as main bioactive compounds of essential oils, their roles in human health and potential application as natural food preservatives. Food Chem X. 2022;13:100217.
CLSI. Performance Standards for Antimicrobial Disk Susceptibility Tests. 13th ed. CLSI standard M02. Wayne, PA: Clinical and Laboratory Standards Institute; 2018.
CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2023.
Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268-81.
Vazquez NM, Mariani F, Torres PS, Moreno S, Galva´n EM. Cell death and biomass reduction in biofilms of multidrug resistant extended spectrum β-lactamase producing uropathogenic Escherichia coli isolates by 1,8-cineole. PLoS One. 2020;15(11):e0241978.
Li L, Shi C, Yin Z, Jia R, Peng L, Kang S, et al. Antibacterial activity of α-terpineol may induce morphostructural alterations in Escherichia coli. Braz J Microbiol. 2015;45(4):1409-13.
Wang Y, Zhang Y, Song X, Fang C, Xing R, Liu L, et al. 1,8-Cineole inhibits biofilm formation and bacterial pathogenicity by suppressing luxS gene expression in Escherichia coli. Front Pharmacol. 2022;13:988245.
Akhmouch AA, Hriouech S, Mzabi A, Tanghort M, Chefchaou H, et al. Synergistic Action of AMX Associated with 1,8-Cineole and Its Effect on the ESBL Enzymatic Resistance Mechanism. Antibiotics 2022;11:1002.
Zengin H, Baysal AH. Antibacterial and Antioxidant Activity of Essential Oil Terpenes against Pathogenic and Spoilage-Forming Bacteria and Cell Structure-Activity Relationships Evaluated by SEM Microscopy. Molecules. 2014;19:17773-98.
